Instagram Outage Disrupts Thousands of U.S. Users 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
NEW YORK, March 13, 2017 -- Chicago-based R1 RCM Inc. (OTC Pink:ACHI) (“R1” or the “Company”), a leading provider of revenue cycle management and physician advisory services to healthcare providers, announced today that it has received approval to list on the Nasdaq Capital Market effective at the opening of trading on Wednesday, March 15, 2017. Joe Flanagan, R1’s President and CEO, will ring the opening bell in honor of the occasion. The Company’s new stock symbol will be RCM (NASDAQ:RCM).
“Listing on Nasdaq is a key milestone for R1 and reflects the progress we continue to make as we embark on our next phase of growth,” said Flanagan. “We are thrilled to be listed on one of the most dynamic markets in the world and look forward to the opportunities this listing will provide.”
About R1 RCM
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, partner engagement strategies, or settings of care. The company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more visit: r1rcm.com.
Contacts: R1 RCM Inc. Investor Relations: Atif Rahim 312-324-5476 [email protected] Media Relations: Deborah Lacy 650-814-7125 [email protected]
